Mesenchymal stromal cells (MSC) as carriers of IL-12 cDNA in treatment of mice with melanoma B16-F10 and metastases
2015/17/N/NZ4/02738
Keywords
Descriptors
- NZ4_12: Inne zagadnienia pokrewne
- NZ5_7: Leczenie chorób człowieka
Panel
NZ4 – Biology of tissues, organs and organisms: morphology and functions of animal's and human's systems, organs and organisms, experimental medicine, basics of neurology
Host institution
Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Oddział w Gliwicach
Voivodeship: mazowieckie
Principal investigator (from the host institution)
Number of co-investigators in the project: 3
Call
PRELUDIUM 9 – announced on 2015-03-16
- Amount awarded
- 149 400 PLN
- Project start date
- 2016-03-16
- Project end date
- 2019-09-15
- Project duration
- 42 months (the same as in the proposal)
- Project status
- Project settled
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publication in academic press/journals (2)
-
Mesenchymal stromal cells as carriers of IL-12 reduce primary and metastatic tumors of murine melanoma
- Authors:
- Natalia Kułach, Ewelina Pilny, Tomasz Cichoń, Justyna Czapla, Magdalena Jarosz-Biej, Marek Rusin, Alina Drzyzga, Sybilla Matuszczak, Stanisław Szala, Ryszard Smolarczyk
- Academic press:
- Scientific Reports (year: 2021, volume: 11, pages: -), Publisher: Nature Publishing Group
- Status:
- Published
- DOI:
- 10.1038/s41598-021-97435-9 – link to the publication
-
Combination of anti-vascular agent - DMXAA and HIF-1α inhibitor - digoxin inhibits the growth of melanoma tumors
- Authors:
- Ryszard Smolarczyk, Tomasz Cichoń, Ewelina Pilny, Magdalena Jarosz-Biej, Aleksandra Poczkaj, Natalia Kułach, Stanisław Szala
- Academic press:
- Scientific Reports volume 8 (year: 2018, volume: 8, pages: 7355), Publisher: Nature Publishing Group
- Status:
- Published
- DOI:
- 10.1038/s41598-018-25688-y – link to the publication
Articles in post-conference publications (4)
-
The effectiveness of anti-vascular DMXAA combined with brachytherapy in anticancer therapy.
- Authors:
- Alina Hadyk, Tomasz Cichoń, Piotr Wojcieszek, Zbigniew Urbaś, Ewelina Pilny, Magdalena Jarosz-Biej, Stanisław Szala, Natalia Kułach, Ryszard Smolarczyk
- Conference:
- XXII Gliwice Scientific Meeting 2018 (year: 2018, pages: 94), Publisher: Association for the Support of Cancer Research
- Date:
- conference 16-17.09
- Status:
- Published
-
Combination of antivascular agent-DMXAA and inhibitor of HIF-1α -digoxin inhibited melanoma tumor growth.
- Authors:
- Ryszard Smolarczyk, Tomasz Cichoń, Ewelina Pilny, Magdalena Jarosz-Biej, Aleksandra Poczkaj, Natalia Kułach, Stanisław Szala.
- Conference:
- XXI Gliwice Scientific Meetings 2017 (year: 2017, pages: 154), Publisher: Association for the Support of Cancer Research
- Date:
- conference 17-18.09
- Status:
- Published
-
Mesenchymal Stromal Cells (MSC) as carriers of IL-12 cDNA in treatment of mice bearing melanowa B16-F10.
- Authors:
- Natalia Kułach, Tomasz Cichoń, Magdalena Jarosz-Biej, Marek Rusin, Ewelina Pilny, Stanisław Szala, Ryszard Smolarczyk
- Conference:
- XXI Gliwice Scientific Meetings (year: 2017, pages: 182), Publisher: Association for the Support of Cancer Research
- Date:
- conference 17-18.09
- Status:
- Published
-
IL-12 Secreted by modified MSC significantly reduces the volume of primary tumors and the number of lung metastases of murine melanoma.
- Authors:
- Natalia Kułach, Magdalena Jarosz-Biej, Tomasz Cichoń, Ewelina Pilny, Marek Rusin, Alina Hadyk, Stanisław Szala, Ryszard Smolarczyk
- Conference:
- XXII Gliwice Scientific Meeting 2018 (year: 2018, pages: 93), Publisher: Association for the Support of Cancer Research
- Date:
- conference 16-17.09
- Status:
- Published